Brevetto n. U.S. Patent Application No. 62/233,162, TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS.
Eugenie Nepovimova;Elisa Uliassi;Jan Korabecny;Luis Emiliano Peña-Altamira;Sarah Samez;Alessandro Pesaresi;Gregory E. Garcia;Manuela Bartolini;Vincenza Andrisano;Christian Bergamini;Romana Fato;Doriano Lamba;Marinella Roberti;Kamil Kuca;Barbara Monti;Maria Laura Bolognesi, Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects, «JOURNAL OF MEDICINAL CHEMISTRY», 2014, 57, pp. 8576 - 8589 [articolo]
Federica Belluti;Elisa Uliassi;Giacomo Veronesi;Christian Bergamini;Marcel Kaiser;Reto Brun;Angelo Viola;Romana Fato;Paul A. M. Michels;R. Luise Krauth-Siegel;Andrea Cavalli;Maria Laura Bolognesi, Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi, «CHEMMEDCHEM», 2014, 9, pp. 371 - 382 [articolo]
F. Prati;E. Uliassi;M. L. Bolognesi, Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases, «MEDCHEMCOMM», 2014, 5, pp. 853 - 861 [articolo]
